Aterian (NASDAQ:ATER – Get Free Report) posted its quarterly earnings data on Friday. The company reported ($0.43) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.26), Zacks reports. The company had revenue of $0.01 million for the quarter, compared to analysts’ expectations of $20.30 million. Aterian had a negative return on equity of 82.05% and a negative net margin of 39.56%.
Aterian Stock Up 3.4%
Shares of NASDAQ:ATER traded up $0.02 during midday trading on Friday, reaching $0.50. The company’s stock had a trading volume of 128,523 shares, compared to its average volume of 481,327. The firm has a market capitalization of $5.44 million, a P/E ratio of -0.19 and a beta of 0.78. Aterian has a 12-month low of $0.35 and a 12-month high of $1.87. The firm has a 50 day moving average of $0.97 and a 200-day moving average of $0.84.
Wall Street Analyst Weigh In
ATER has been the topic of a number of research reports. Wall Street Zen cut shares of Aterian from a “hold” rating to a “sell” rating in a report on Saturday, July 25th. Weiss Ratings raised Aterian from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, May 19th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Sell”.
Institutional Trading of Aterian
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Citadel Advisors LLC raised its stake in Aterian by 222.0% during the third quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock valued at $35,000 after buying an additional 22,865 shares during the last quarter. Susquehanna International Group LLP raised its position in shares of Aterian by 310.2% in the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock worth $43,000 after purchasing an additional 30,637 shares during the last quarter. Goldman Sachs Group Inc. grew its position in Aterian by 73.0% during the 1st quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after purchasing an additional 9,026 shares during the last quarter. Finally, XTX Topco Ltd purchased a new stake in Aterian during the 2nd quarter valued at about $55,000. Hedge funds and other institutional investors own 7.02% of the company’s stock.
About Aterian
Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.
Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.
Read More
- Five stocks we like better than Aterian
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
- AirJoule Technologies: Short Squeeze Setup Amid Rising Risks
- MarketBeat Week in Review – 08/10 – 08/14
Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.
